CareDx Inc
For the period ended Dec 31, 2024. Filed Feb 28, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 28, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
Our headquarters are located in Brisbane, California. We lease facilities in North America, Europe, and Australia. The following is a summary of the locations, functions and approximate square footage of those facilities as of December 31, 2024:
| Location | Function | Square Footage |
|---|---|---|
| United States | ||
| Brisbane, California | Corporate headquarters | 26,506 |
| Brisbane, California | Research & development and clinical laboratories | 61,444 |
| West Chester, Pennsylvania | Sales office and distribution | 6,336 |
| Omaha, Nebraska | Digital solutions office | 24,984 |
| Columbus, Ohio | Digital solutions office | 3,806 |
| Flowood, Mississippi | Transplant pharmacy | 4,800 |
| Europe | ||
| Stockholm, Sweden | Research & development and product manufacturing | 24,940 |
| Australia | ||
| Fremantle | Research & development | 5,199 |
We do not own any real property. We believe that our leased facilities are adequate to meet our current needs and that additional facilities are available for lease to meet future needs.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.